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Abstract
Editors from a number of medical journals lay out principles for journals considering publication of Comparative 
Effectiveness Research (CER). In order to encourage dissemination of this editorial, this article is freely available in PLoS 
Medicine and will be also published in Medical Decision Making, Croatian Medical Journal, The Cochrane Library, Trials, 
The American Journal of Managed Care, and Journal of Clinical Epidemiology.
In order to optimize health outcomes within the con-
straints of inevitably limited resources, low- and high-
income countries alike require unbiased means of assess-
ing health care interventions for their relative effective-
ness. Such interventions include diagnostic tests and
treatments (both established and newly developed) and
implementation of health policy [1]. Likewise, health care
professionals and patients need better information to
inform health care decisions that require weighing bene-
fits and risks in light of the patient's medical history and
personal preferences.
Some countries and international organizations have
recognized the need for such evidence and are already
allocating funds for research to provide it [2]. The WHO
Ministerial Summit in Mexico called for the establish-
ment of support for a substantive and sustainable pro-
gram of health systems research aligned with countries'
priority needs and aimed at achieving internationally
agreed-upon health-related development goals, including
those contained in the United Nations Millennium Dec-
laration [3]. The UK has established the National Insti-
tute for Health Research to commission and disseminate
research that supports decision making by professionals,
policy makers and patients and to ensure that the UK's
health system, the National Health Service, has access to
the best possible evidence to inform decisions and
choices [4].
The US is now addressing similar goals with an initia-
tive known as comparative effectiveness research (CER).
In 2008, a report by the US Institute of Medicine (IOM)
noted that patient care "should be based on the conscien-
tious, explicit, and judicious use of current best evidence"
[1]. In legislation that allocated US $1.1 billion in the US
for CER on health care practices in 2009, the US Con-
gress mandated that the IOM set national priorities for
CER clinical topics. The IOM defined CER as "The gener-
ation and synthesis of evidence that compares the bene-
fits and harms of alternative methods to prevent,
diagnose, treat, and monitor a clinical condition, or to
improve the delivery of care" [5]. The definition further
stated that "The purpose of CER is to assist consumers,
clinicians, purchasers, and policy makers to make
informed decisions that will improve health care at both
the individual and population levels."
To the authors and endorsers of the present Editorial,
the potential value of research with these characteristics
is self-evident. The challenge will be to realize the full
potential of such research to improve health. Doing so
will require assessing a heterogeneous body of evidence
consisting of prospective randomized trials--including
pragmatic trials--and observational research using data
obtained in the course of regular practice. Hence, medical
journals must use rigorous approaches, including but not
limited to peer review by independent experts, to assess
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the limitations inherent in such research, such as missing
data, incomplete follow-up, unmeasured biases, the
potential role of chance, competing interests, and selec-
tive reporting of results.
Drawing on many years of collective experience in
assessing these issues in the course of evaluating health
research through peer review, we support the following
principles and standards for CER.
Principles of CER
• The principal goal of CER is to allow decision mak-
ers (patients, clinicians, purchasers, and policy mak-
ers) to make informed decisions on specific health
practices. CER aims to identify and fill knowledge
gaps that underlie uncertainties in practice.
• CER may provide information about individual and
population benefits, harms, costs, and logistics of dif-
ferent policies or treatments.
• CER will apply to a broad range of interventions,
tests, and strategies for prevention, care delivery, and
quality of care
• CER should directly compare tests or active treat-
ments--so-called head-to-head comparisons--of via-
ble clinical alternatives within the current standard of
practice (which in some cases may be no interven-
tion).
• CER should primarily assess patient-relevant out-
comes, but should also compare the economic impli-
cations of different approaches to prevention and
care.
• CER should assist patients and physicians to choose
between effective treatments. To this end, CER
should identify patient characteristics that are associ-
a t e d  w i t h  m e a n i n g f u l  d i f f e r e n c e s  i n  o u t c o m e s .
Researchers should collect and analyze the data nec-
essary to achieve this goal according to a pre-speci-
fied plan that clearly indicates specific hypotheses
and the methods to test them.
• The scope of CER includes new data, old data newly
analyzed, and systematic reviews of existing research.
Standards for the Conduct and Reporting of CER
• CER studies should follow the highest scientific
standards for design, analysis, and interpretation and
should adhere to reporting guidelines [6] that build
upon initiatives to improve the quality and transpar-
ency of clinical science.
• Every CER study should have a research protocol,
written in advance and addressing the key research
question(s), methods, and planned analyses.
Researchers should record all changes in the protocol.
These protocols should be publicly accessible.
• Patients and other decision-makers should be
involved in selecting and refining topics for CER.
• The study population for CER should be representa-
tive of clinical practice or the relevant public health
practice.
• To increase transparency about selective publica-
tion, researchers should register CER studies before
initiation, in a publicly available registry.
• To increase transparency about the practice of pre-
senting post-hoc analyses as conclusive results, study
registration should include a clear statement of study
hypotheses, outcomes, and analysis plan.
• CER studies must undergo rigorous peer review by
independent topical, methodological, and statistical
experts.
•  T o  e nsu r e  a c c es s ibili t y t o t he  aff ect ed pub lic a nd
other researchers, journals (or other sites of publica-
tion) should make all CER studies freely available and
archive them in a public repository, such as PubMed
Central.
• Reports of CER must include a frank discussion of
each study's limitations, including biases, confound-
ing, and scope of applicability.
• Given the potential impact of CER on the profitabil-
ity of the interventions being evaluated, researchers
performing CER studies must commit to stringent
and enforceable competing interest policies [7].
• Researchers, funders, and other contributors to a
CER study must clearly state all relevant competing
interests at the time of peer review, and publicly upon
publication in any forum.
Medical journals are the primary evaluators and dis-
seminators of peer-reviewed health research. As such,
they must ready themselves to play a crucial role in advo-
cating for CER, advancing CER methods and facilitating
the translation of CER results into practice. Most impor-
tantly, journals and peer reviewers must do their part to
ensure that CER, like all research with relevance to
health, meets the highest scientific and ethical standards.
They must therefore develop the methodological and sta-
tistical expertise to properly evaluate new or unfamiliar
methods of health care research.
We recognize that CER has the potential to substan-
tially improve decision-making about existing and new
approaches to health care. To fulfill this potential,
researchers must adopt stringent methods, and medical
journals must hold them to high standards of ethics, sci-
entific rigor, and reporting.
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